Ms. Schuman also makes recommendations to orthopedic and cardiovascular medical device companies. At SHA, she is responsible for the review and synthesis of proposed and final Centers for Medicare and Medicaid Services rules, focusing on how companies are impacted by new regulations.
Ms. Schuman also assists with clinical trial agreement development, negotiation and reimbursement protocol review. She previously served a large non-profit and performed regulatory analysis for a small firm in Washington, D.C.
More Articles on Spine Industry:
Deconstructing the Cost of Spine Care: Where Dollars Really Go
5 Findings on Spine Surgery Rehabilitation Effectiveness
Medtronic’s $22M Infuse Settlement: 5 Thigns to Know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.